Tech.
HugroPeptides
The Self-Regenerative Code
While others import alien compounds, we speak skin's native language. HugroPeptides™ are endogenous protein architects that orchestrate skin's autoregulation:
BONYX merges surface renewal with dermal vitality. By leveraging skin's native peptides—the architects of structural integrity—our formulations stimulate self-repair mechanisms, strengthening collagen-elastin architecture to diminish aging traces and reboot skin's regenerative blueprint.
Bonyx Ingredients
HugroPeptides, pioneered through biotechnological innovation
Our scientific team harnesses peptides—naturally occurring in the human body—as foundational elements in high-efficacy formulations.
Meticulously curating 18 bioactive compounds, each precisely calibrated to address distinct skin concerns with synergistic precision,
we integrate these advancements exclusively into Bonyx's proprietary systems.
Bio Materials Transdermal System
BMTS
"205% Deeper Bioactive Delivery –
Redefining Transdermal Efficacy"
Skin’s most vulnerable cells reside in deeper epidermal strata, where conventional ingredients fail to penetrate.
BMTS—our patented macromolecular transport technology—overcomes cutaneous absorption barriers, delivering hydrophilic/hydrophobic actives with subcellular precision.
By engineering actives with BMTS-enhanced bioavailability, we ensure target-specific cellular engagement, transforming inert ingredients into therapeutic interventions exactly where skin demands repair.
Anti Ubiquitination Technology
AUT
"8x Prolonged Bioactivity-Defying Molecular Degradation" Merely delivering actives to target cells is insufficient—their therapeutic potential hinges on sustained bioavailability.
AUT, our patented molecular stabilization platform, selectively modulates the ubiquitin-proteasome system to decelerate peptide degradation at its origin.
While conventional actives dissipate within 2–3 hours post-absorption, AUT-engineered formulations attenuate proteasomal degradation kinetics, extending bioactive half-lives by 200-300% (up to 8x in optimized conditions).
This radical extension transforms transient interventions into enduring cutaneous reprogramming.
Bonyx leverages AUT to anchor therapeutic actives within skin’s biological memory, ensuring persistent efficacy aligns with tissue regeneration chronobiology.